[صفحه اصلی ]   [Archive]  
:: صفحه اصلي :: درباره نشريه :: آخرين شماره :: تمام شماره‌ها :: جستجو :: ثبت نام :: ارسال مقاله :: تماس با ما ::
بخش‌های اصلی
صفحه اصلی::
اطلاعات نشریه::
برای نویسندگان::
آرشیو مجله و مقالات::
برای داوران::
ثبت نام و اشتراک::
تماس با ما::
تسهیلات پایگاه::
بایگانی مقالات زیر چاپ::
::
جستجو در پایگاه

جستجوی پیشرفته
..
دریافت اطلاعات پایگاه
نشانی پست الکترونیک خود را برای دریافت اطلاعات و اخبار پایگاه، در کادر زیر وارد کنید.
..
:: دوره 1، شماره 2 - ( 10-1388 ) ::
جلد 1 شماره 2 صفحات 46-39 برگشت به فهرست نسخه ها
Serum resistin a biomarker of type II diabetes development
چکیده:   (10901 مشاهده)
Background: Resistin and ghrelin are hormones that have roles in the glucose and lipid homeostasis and weight regulation. Human studies regarding resistin and ghrelin in diabetic patients are scarce, especially in the cases of normotensive and non-obese patients. This study was designed to illuminate some of the missing points.
Methods: Eighty diabetic patients and eighty healthy individuals participated in this study according to the inclusion criteria [age, gender, body mass index (BMI), blood pressure (BP) and diabetes type]. Fasting and postprandial glucose, hemoglobin A1c (HbA1c), insulin, acylated-ghrelin and resistin were evaluated for all the participants while HOMA and QUICKI were calculated.
Results: Fasting and postprandial glucose, HbA1c, insulin and calculated HOMA increased, while QVICKI decreased among the diabetic patients (p<0.001). All patients also had reduced acylated-ghrelin that was more predominant among type I cases (p<0.001), while resistin was significantly reduced among the female patients (p<0.001). Furthermore, a significant negative correlation between circulating insulin and resistin of older healthy subjects [female (R=-0.72, p<0.001) and male (R=-0.59, p<0.01)] was detected which was absent for the patient groups.
Conclusion: None of the diabetes indicators correlated with the circulating ghrelin or resistin that may indicate reductions in the results of protective phenomena due to excess glucose, increase insulin, or high circulating lipids usually observed among the diabetic patients. On the other hand, a strong negative correlation between the insulin and resistin among the older (38-55 years) healthy individuals that indicate the rise of resistin can be a sign of initiation of type II diabetes.
متن کامل [PDF 194 kb]   (2222 دریافت)    
نوع مطالعه: Original Article | موضوع مقاله: Infectious Diseases
دریافت: 1392/10/24 | پذیرش: 1392/10/24 | انتشار: 1392/10/24
ارسال نظر درباره این مقاله
نام کاربری یا پست الکترونیک شما:

CAPTCHA


XML   English Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Moshtaghi Kashanian G R, Forohar D, Sanjari M. Serum resistin a biomarker of type II diabetes development. Caspian J Intern Med 2010; 1 (2) :39-46
URL: http://caspjim.com/article-1-75-fa.html

Serum resistin a biomarker of type II diabetes development. 1. 1388; 1 (2) :39-46

URL: http://caspjim.com/article-1-75-fa.html



بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.
دوره 1، شماره 2 - ( 10-1388 ) برگشت به فهرست نسخه ها
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645